# OnCo record hookipa-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hookipa-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hookipa-pharma" ;
  schema:name "Hookipa Pharma"@en ;
  schema:alternateName "HOOKIPA Pharma Inc."@en, "Hookipa Biotech"@en, "NASDAQ:HOOK"@en ;
  schema:description "Hookipa Pharma is a Vienna biotech that engineers arenaviruses into vaccines that drive unusually strong killer T-cell responses; HB-200 targets the HPV16 proteins that cause many head and neck cancers."@en ;
  schema:url <https://onco.cc/companies/hookipa-pharma/>, <https://www.hookipapharma.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.hookipapharma.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "AT" ;
  onco:drugs <https://onco.cc/drugs/hb-200/> .